Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Aleksi Hupli. (2023) Instrumentalising therapeutic and enhancement drugs as pharmacological technologies with politicogenic drug effects. Drugs: Education, Prevention and Policy 30:1, pages 60-69.
Read now
Read now
Veljko Dubljević, Katharina Trettenbach & Robert Ranisch. (2022) The Socio-Political Roles of Neuroethics and the Case of Klotho. AJOB Neuroscience 13:1, pages 10-22.
Read now
Read now
Erin C. Conrad, Stacey Humphries & Anjan Chatterjee. (2019) Attitudes Toward Cognitive Enhancement: The Role of Metaphor and Context. AJOB Neuroscience 10:1, pages 35-47.
Read now
Read now
Sebastian Porsdam Mann, Pablo de Lora Deltoro, Thomas Cochrane & Christine Mitchell. (2018) Is the use of modafinil, a pharmacological cognitive enhancer, cheating?. Ethics and Education 13:2, pages 251-267.
Read now
Read now
Constantin Wiegel, Sebastian Sattler, Anja S. Göritz & Martin Diewald. (2016) Work-related stress and cognitive enhancement among university teachers. Anxiety, Stress, & Coping 29:1, pages 100-117.
Read now
Read now
Veljko Dubljevic & Christopher James Ryan. (2015) Cognitive enhancement with methylphenidate and modafinil: conceptual advances and societal implications. Neuroscience and Neuroeconomics 4, pages 25-33.
Read now
Read now
Veljko Dubljević. (2014) Response to Open Peer Commentaries on “Prohibition or Coffee Shops: Regulation of Amphetamine and Methylphenidate for Enhancement Use by Healthy Adults”. The American Journal of Bioethics 14:1, pages W1-W8.
Read now
Read now
Neil Levy. (2013) There May Be Costs to Failing to Enhance, as Well as to Enhancing. The American Journal of Bioethics 13:7, pages 38-39.
Read now
Read now
Julian Savulescu. (2013) A Liberal Consequentialist Approach to Regulation of Cognitive Enhancers. The American Journal of Bioethics 13:7, pages 53-55.
Read now
Read now
Yvette van der Eijk. (2013) Tobacco: Prohibition, Coffee Shops, or Discouragement?. The American Journal of Bioethics 13:7, pages 51-53.
Read now
Read now
Anders Sandberg. (2013) Enhancement Policy and the Value of Information. The American Journal of Bioethics 13:7, pages 34-35.
Read now
Read now
Wayne Hall, Brad Partridge & Jayne Lucke. (2013) Constraints on Regulatory Options for Putatively Cognitive Enhancing Drugs. The American Journal of Bioethics 13:7, pages 35-37.
Read now
Read now
HenryT. Greely. (2013) Some First Steps Toward Responsible Use of Cognitive-Enhancing Drugs by the Healthy. The American Journal of Bioethics 13:7, pages 39-41.
Read now
Read now
C.D. Brewer & Heather DeGrote. (2013) Regulating Methylphenidate: Enhancing Cognition and Social Inequality. The American Journal of Bioethics 13:7, pages 47-49.
Read now
Read now
Jessica Flanigan. (2013) An Argument for Permitting Amphetamines and Instant-Release Methylphenidate. The American Journal of Bioethics 13:7, pages 49-51.
Read now
Read now
Cynthia Forlini, Eric Racine, Jochen Vollmann & Jan Schildmann. (2013) How Research on Stakeholder Perspectives Can Inform Policy on Cognitive Enhancement. The American Journal of Bioethics 13:7, pages 41-43.
Read now
Read now
Jamie
Nicole LaBuzetta. (2013) Moving Beyond Methylphenidate and Amphetamine: The Ethics of a Better “Smart Drug”. The American Journal of Bioethics 13:7, pages 43-45.
Read now
Read now
Nadira Faulmüller, Hannah Maslen & Filippo
Santoni de Sio. (2013) The Indirect Psychological Costs of Cognitive Enhancement. The American Journal of Bioethics 13:7, pages 45-47.
Read now
Read now
Articles from other publishers (22)
Michael Menconi & Veljko Dubljević. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
713
738
.
John Mann. (2021) Cognitive enhancing drug use by students in the context of neoliberalism: cheating? Or, a legitimate expression of competitive entrepreneurialism?. International Journal of Drug Policy 95, pages 102907.
Crossref
Crossref
Eric Racine, Sebastian Sattler & Wren Boehlen. (2021) Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior. Science and Engineering Ethics 27:2.
Crossref
Crossref
Aleksi Hupli. (2020) Cognitive enhancement with licit and illicit stimulants in the Netherlands and Finland: what is the evidence?. Drugs and Alcohol Today 20:1, pages 62-73.
Crossref
Crossref
Michael Menconi & Veljko Dubljević. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
26
.
Veljko Dubljević, Iris Coates McCall & Judy Illes. 2020. Organizational Neuroethics. Organizational Neuroethics
87
103
.
Aleksi Hupli, Moritz Berning, Ahnjili Zhuparris & James Fadiman. (2019) Descriptive assemblage of psychedelic microdosing: Netnographic study of Youtube™ videos and on-going research projects. Performance Enhancement & Health 6:3-4, pages 129-138.
Crossref
Crossref
Sebastian Sattler. (2018) Nonmedical use of prescription drugs for cognitive enhancement as response to chronic stress especially when social support is lacking. Stress and Health 35:2, pages 127-137.
Crossref
Crossref
Veljko DubljevićVeljko Dubljević. 2019. Neuroethics, Justice and Autonomy: Public Reason in the Cognitive Enhancement Debate. Neuroethics, Justice and Autonomy: Public Reason in the Cognitive Enhancement Debate
45
63
.
Veljko Dubljević & Eric Racine. 2019. Shaping Children. Shaping Children
199
212
.
Veljko Dubljević & Robert Ranisch. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
8
.
Ashley R. Bullard. (2018) Neither Licit nor Illicit. Contemporary Drug Problems 45:3, pages 262-282.
Crossref
Crossref
Veljko Dubljević. (2018) Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies. Frontiers in Pharmacology 9.
Crossref
Crossref
Nathalie Voarino, Veljko Dubljević & Eric Racine. (2017) tDCS for Memory Enhancement: Analysis of the Speculative Aspects of Ethical Issues. Frontiers in Human Neuroscience 10.
Crossref
Crossref
Arnaldo Zelli, Fabio Lucidi & Luca Mallia. (2015) The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective. Frontiers in Psychology 6.
Crossref
Crossref
Veljko Dubljević. (2014) Neurostimulation Devices for Cognitive Enhancement: Toward a Comprehensive Regulatory Framework. Neuroethics 8:2, pages 115-126.
Crossref
Crossref
Cynthia Forlini, Jan Schildmann, Patrik Roser, Radim Beranek & Jochen Vollmann. (2014) Knowledge, Experiences and Views of German University Students Toward Neuroenhancement: An Empirical-Ethical Analysis. Neuroethics 8:2, pages 83-92.
Crossref
Crossref
Barbara J Sahakian & Sharon Morein-Zamir. (2015) Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people. The Lancet Psychiatry 2:4, pages 357-362.
Crossref
Crossref
Veljko Dubljević. 2015. Cognitive Enhancement. Cognitive Enhancement
343
365
.
Veljko Dubljević, César Venero & Shira Knafo. 2015. Cognitive Enhancement. Cognitive Enhancement
1
9
.
SangMok Lee & 최종현. (2014) Safety Issues in Neuroenhancement. Korean Journal of Medical Ethics 17:3, pages 349-362.
Crossref
Crossref
Sebastian Sattler, Guido Mehlkop, Peter Graeff & Carsten Sauer. (2014) Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics. Substance Abuse Treatment, Prevention, and Policy 9:1.
Crossref
Crossref